Hot Flasher

Hot Flasher
  • 5.0 (2)
  • Sexuality
  • Updated Daily

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

  1. 10h ago

    Kidney Stones, Scotland's New Drug, and Menopause Goes to Work

    A new study published in the NAMS journal Menopause links premature menopause to significantly higher risk of kidney stone disease across two large datasets, including the UK Biobank. Scotland has approved the first non-hormonal menopause drug, expanding options for women who can't or won't use hormone therapy. And Washington State's governor has signed an executive order requiring workplace support for employees experiencing perimenopause and menopause. Key Takeaways: • Women who experienced premature menopause (before age 40) showed a consistently higher risk of kidney stone disease across both UK Biobank and NHANES cohorts, with the association holding up across multiple analytical methods. • Hormone therapy did not meaningfully modify the kidney stone risk, suggesting the connection may be driven by genetic or metabolic factors rather than estrogen loss alone. • Scotland has approved a non-hormonal drug for menopause symptoms — significant news for the substantial number of women who cannot use or choose not to use HRT. • Washington Governor Bob Ferguson signed an executive order directing state agencies to support employees experiencing perimenopause and menopause in the workplace, making Washington one of the more concrete US policy actors on this issue. • The kidney stone–premature menopause link is a reminder that early menopause has downstream health consequences beyond the cardiovascular and bone density risks that get most of the attention. Sources & References: • Premature menopause and risk of kidney stone disease: UK Biobank and NHANES evidence (https://pubmed.ncbi.nlm.nih.gov/42445973/) - Menopause (NAMS Journal) • First non-hormonal menopause drug approved in Scotland (https://news.google.com/rss/articles/CBMiowFBVV95cUxOSnY1VGIxdzdROF9KbjNhc09SbFBXQWpNa2ZCS1FMTWtyY0gzbFg3Tm1SOEE1SjRTZUdOSHBJMktkSVlJSEk1ZVRvVGVVejFxaThlQmt4aWh5ZUJZeXVKWGFRNnYyNDk5clhoSC1oLVNtTExVSmtCcmNhbFFOUG11VG9XTy1JbkRhbUI0NjBhVlQ0ME1xNWpJNEZoQ0c5b09sTmJ3?oc=5) - Medscape via Google News • Governor Ferguson signs Executive Order supporting women experiencing perimenopause and menopause in the workplace (https://news.google.com/rss/articles/CBMixwFBVV95cUxNdkFQMEtfUUp1QVpITmdaR0ljbVFnUWg3MFlYclprbTdfa2RMWjNIOU5aTWRSOFhJYU1TMXFfNnhkNUFjWWhOeHZSM19ER3JKYlEtN1pYbjF2YVdXeXJuR3dLR0dvN1QxVjVzTGFlSXdrMTQyelRXV1ppZUFFSzJybXJfVm82OUZUdWw1cjBIMHY1cEtvOWxHMEIxZmlDT1V0TUVVV1JZM1h5S216amZSQ2djSnlhcGloTHotcHJicDhORkQwSzNJ?oc=5) - Governor Bob Ferguson (.gov) via Google News Listen with full show notes: https://hotflasher.com/episodes/2026-07-16-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  2. 1d ago

    Your Medical Record Is Missing Half the Story

    A new study used Reddit posts to map menopause symptoms that consistently go undocumented in clinical records — and the gap is significant. Scotland has approved fezolinetant (Veoza), the first non-hormonal drug specifically licensed for menopause symptoms. And a 2026 PubMed study found that air pollution — specifically nitrogen oxide and sulfur dioxide — accelerates bone loss in postmenopausal women, with social determinants shaping who bears the most risk. Key Takeaways: • Reddit data revealed a wider range of menopause symptoms than what appears in clinical medical records, suggesting clinical documentation consistently undercaptures what women actually experience. • Scotland has approved fezolinetant (brand name Veoza), a neurokinin 3 receptor antagonist, as the first non-hormonal prescription option specifically licensed for menopause vasomotor symptoms. • A 2026 study published in PubMed found that nitrogen oxide and sulfur dioxide exposure is associated with measurable bone damage in postmenopausal women in the United States. • The air pollution–bone loss connection is shaped by social determinants — women with lower income and less access to resources face disproportionately higher risk from the same pollution levels. • Bone loss after menopause is not purely hormonal; environmental exposures and social circumstances are factors the standard clinical conversation almost never includes. Sources & References: • Reddit exposes menopause symptoms often missing from medical records (https://news.google.com/rss/articles/CBMitwFBVV95cUxOYjV6QmVBTjkzRl95S1NsbTJ5ajlseWltYlExZWlvSDhHTG1iT3dpSmZoWFEtWDJ0N1hGS0d5ODBkTURSOTN0d2JfcmdyMVB3NVBPUmhsX242R3VRZzRrRjBzbDlrZkk2ZjdSaE1JUjdYMGF0LV9FQmdRaFlUY1habHZEZUtnMGtWYTEwUlo1NUtTQm9zLVRkX0lWQzQyWm1kOWIxQ21rb1gxdzhlU21sT2JfQzNwWm8?oc=5) - News-Medical • First Non-Hormonal Menopause Drug Approved in Scotland (https://news.google.com/rss/articles/CBMiowFBVV95cUxPSnY1VGIxdzdROF9KbjNhc09SbFBXQWpNa2ZCS1FMTWtyY0gzbFg3Tm1SOEE1SjRTZUdOSHBJMktkSVlJSEk1ZVRvVGVVejFxaThlQmt4aWh5ZUJZeXVKWGFRNnYyNDk5clhoSC1oLVNtTExVSmtCcmNhbFFOUG11VG9XTy1JbkRhbUI0NjBhVlQ0ME1xNWpJNEZoQ0c1b09sTmJ3?oc=5) - Medscape • Social determinants of vulnerability to nitrogen oxide- and sulfur dioxide-related bone damage among postmenopausal women in the United States (https://pubmed.ncbi.nlm.nih.gov/42454308/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-07-15-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  3. 2d ago

    Your Joints Know Before You Do: Cartilage, Apps & Hormone Chaos

    This episode digs into a new study linking subclinical cartilage degradation to bone density and trace element levels in women with osteopenia and osteoporosis — and why the "subclinical" part matters most. Nykki also looks at a PubMed review on menopause apps and the gap between what they promise and what the evidence supports, plus a fertility-window study with implications that extend well into perimenopause. Key Takeaways: • Cartilage degradation in women with osteopenia and osteoporosis may be measurable before symptoms appear, suggesting bone and joint protection strategies may need to start earlier than most women are told. • Trace elements — including zinc and selenium — showed associations with cartilage and bone health in postmenopausal women in the Abbood et al. study, though the research is observational and can't establish cause. • A 2026 PubMed review found menopause apps vary widely in clinical accuracy; some provide useful symptom tracking, but others make claims that outrun the evidence behind them. • Urine hormone monitoring for fertile window modeling (Bouchard et al.) shows meaningful hormonal variability across the reproductive lifespan — which has direct relevance for perimenopausal women still trying to understand their cycles. • Symptom-tracking apps are most useful as a conversation starter with a clinician, not as a substitute for one. Sources & References: • Menopause apps offer empowerment but pose risks (https://pubmed.ncbi.nlm.nih.gov/42444043/) - PubMed • Modeling fertile window differences across the reproductive lifespan with urine hormone monitoring (https://pubmed.ncbi.nlm.nih.gov/42443950/) - PubMed • Subclinical cartilage degradation, bone density, and trace elements in peri- and postmenopausal women with osteopenia and osteoporosis (https://pubmed.ncbi.nlm.nih.gov/42442971/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-07-14-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  4. 3d ago

    HRT With Complications, Brain Scans, and Why How Hard You Run Matters

    This episode covers three new papers published July 2026: a systematic review examining HRT safety across women with common health conditions, a methodological critique of how brain-menopause research gets interpreted, and a head-to-head exercise study testing whether intensity level matters for postmenopausal cardiovascular health. Research credibility is the through-line — all three papers are worth understanding on their own terms, not just their headlines. Key Takeaways: • A new 2026 systematic review suggests HRT risk-benefit calculations look different depending on specific comorbidities — cardiovascular disease, diabetes, and osteoporosis each carry distinct considerations, and blanket avoidance is not supported across the board. • A published response paper challenges how cross-sectional study designs are being used to draw conclusions about menopause and brain health — the limitation is about causality, not about whether the brain-menopause connection is real. • A 2026 RCT found that higher-intensity aerobic exercise produced meaningfully better improvements in cardiorespiratory fitness and cardiometabolic markers in postmenopausal women compared to lower-intensity protocols. • Cross-sectional brain imaging studies can tell us which brain features correlate with menopausal status, but they cannot tell us whether menopause caused those features — that distinction matters for how we interpret the research. • The exercise intensity finding matters practically: moderate-effort walking is not equivalent to vigorous aerobic work when it comes to cardiovascular outcomes in this population. Sources & References: • Systematic review: hormone replacement therapy in postmenopausal women with medical co-morbidities (https://pubmed.ncbi.nlm.nih.gov/42439012/) - PubMed • Response to interpreting cross-sectional comparisons of menopausal status and brain outcomes (https://pubmed.ncbi.nlm.nih.gov/42438864/) - PubMed • Comparative effects of aerobic exercise intensity on cardiorespiratory fitness and cardiometabolic risk in postmenopausal women (https://pubmed.ncbi.nlm.nih.gov/42438853/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-07-13-research-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  5. 6d ago

    Your Childhood, Your Bladder, and a Blindspot in the Ultrasound Room

    A 2026 study links adverse childhood experiences to earlier menopause onset and higher dementia risk — and the biological pathway is more direct than you might expect. This episode also covers why bladder symptoms in menopause keep getting misdiagnosed and undertreated, and a concerning finding about how uterine fibroids can mask endometrial cancer on ultrasound. Key Takeaways: • Women with higher ACE scores had greater rates of early menopause, and early menopause is itself associated with elevated dementia risk — suggesting childhood trauma may set off a chain with long-term cognitive consequences. • Urinary symptoms like urgency, frequency, and recurrent UTIs are often manifestations of genitourinary syndrome of menopause (GSM), not separate conditions — and they respond to estrogen-based treatments that most women are never offered. • A retrospective cohort study found that uterine fibroids significantly reduce ultrasound's ability to detect both endometrioid and serous endometrial cancers, meaning women with fibroids may need additional or alternative imaging if endometrial cancer is a concern. • GSM affects an estimated 50-70% of postmenopausal women but remains dramatically underdiagnosed, in part because clinicians don't ask and patients don't connect the symptoms to menopause. • The fibroid-ultrasound finding is particularly consequential for serous endometrial cancer, which is the more aggressive subtype — a missed or delayed diagnosis carries serious stakes. Sources & References: • Adverse childhood experiences, early menopause, cognition, and dementia risk in older U.S. adults (https://pubmed.ncbi.nlm.nih.gov/42428989/) - PubMed • Urinary manifestations of genitourinary syndrome of menopause: pathophysiology, presentation, and management (https://pubmed.ncbi.nlm.nih.gov/42428460/) - PubMed • Uterine fibroids reduce ultrasound sensitivity for detecting endometrial cancer: retrospective cohort study (https://pubmed.ncbi.nlm.nih.gov/42428452/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-07-10-listener-story Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  6. Jul 9

    Your Brain, Your Headache, and Who Gets Left Behind

    This episode covers three new research items: a 2026 study on how physical activity protects against dementia differently depending on menopausal status, a NAMS journal paper on the largely invisible menopause experience of women with criminal legal system involvement, and fresh WHI clinical trial data on HRT, migraine history, and headache severity. Key Takeaways: • A July 2026 study (Lim et al.) found that physical activity's protective effect against dementia varies by menopausal status — suggesting timing relative to menopause may matter, not just the activity itself. • Women with criminal legal system involvement commonly experience menopausal symptoms, some of them severe, while facing institutional barriers that make accessing care significantly harder than the general population. • New analysis of WHI hormone therapy trial data found associations between menopausal hormone therapy, migraine history, and headache severity — relevant for the large overlap between migraine sufferers and perimenopausal women. • The menopause research landscape still skews heavily toward women with stable housing, healthcare access, and no legal-system involvement — a blind spot with real clinical consequences. • On HRT and migraines: if you have a migraine history and are considering or currently using hormone therapy, this is a conversation to have with your doctor — not a reason to panic, but a data point that matters. Sources & References: • Role of Physical Activity in Protecting Against Dementia According to Menopausal Status (https://pubmed.ncbi.nlm.nih.gov/42421403/) - PubMed • Menopause experience among people with criminal legal system involvement (https://pubmed.ncbi.nlm.nih.gov/42412584/) - Menopause (NAMS Journal) • Menopausal hormone therapy, migraine history, and headache severity: Results from the Women's Health Initiative Hormone Therapy clinical trials (https://pubmed.ncbi.nlm.nih.gov/42419355/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-07-09-influencer-roundup Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  7. Jul 8

    Rhubarb, Heart Risk, and the Appendix Nobody Warned You About

    This episode covers three new studies: a 2026 trial on a rhubarb root extract for perimenopausal migraines, a Chinese study linking a metric called the Cardiometabolic Index to coronary artery disease severity in menopausal women, and a case report on appendix endometriosis that doubles as a reminder of how badly the medical system underestimates this disease. Research credibility lens throughout, with a hard take on the endometriosis case and what it says about diagnostic culture. Key Takeaways: • ERr 731, a standardized extract from rhubarb root, showed statistically significant reductions in headache and migraine frequency in perimenopausal women in a 2026 study — but the trial is small and the funding source warrants scrutiny before drawing strong conclusions. • The Cardiometabolic Index (CMI) — a ratio derived from waist circumference, height, and blood triglycerides — correlated with both the presence and severity of coronary artery disease in a study of menopausal women, and may be a more accessible screening signal than some current clinical tools. • Endometriosis can occur in the appendix, and when it does, it can present as acute appendicitis — the 2026 case report involved a postmenopausal woman, a reminder that endometriosis does not reliably stop at menopause. • Appendix endometriosis is almost never diagnosed before surgery; the diagnosis is typically made by pathology after the appendix is removed. • The endometriosis case highlights a persistent gap: when women present with acute abdominal pain, endometriosis often isn't on the differential — and that's a clinical culture problem, not just a knowledge gap. Sources & References: • ERr 731 rhubarb extract: efficacy for migraine and perimenopausal symptoms (https://pubmed.ncbi.nlm.nih.gov/42416823/) - PubMed • Cardiometabolic Index and coronary artery disease severity in menopausal women (https://pubmed.ncbi.nlm.nih.gov/42416596/) - PubMed • Endometriosis of the vermiform appendix: case report and literature review (https://pubmed.ncbi.nlm.nih.gov/42416415/) - PubMed Listen with full show notes: https://hotflasher.com/episodes/2026-07-08-myth-busting Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

  8. Jul 7

    Your Ovaries Didn't Retire — They Changed Jobs (Into Chaos)

    This episode covers three findings reshaping how we understand menopause and perimenopause: new research suggesting postmenopausal ovaries undergo a cellular identity shift that may fuel chronic inflammation, a lesser-known perimenopause symptom that has women alarmed after Penélope Cruz and Olivia Wilde discussed it publicly, and a study linking lifelong exposure to violence with significantly earlier menopause onset. Key Takeaways: • New research suggests that after menopause, ovaries don't simply become inactive — they may undergo a cellular identity shift that contributes to chronic inflammation, potentially explaining joint pain and fatigue that get dismissed as "just aging." • Penélope Cruz and Olivia Wilde both publicly discussed electric shock sensations — a perimenopause symptom called dysesthesia — sending many women to search for something they'd never been warned about. • A study found that women who experienced lifelong violence had significantly earlier menopause onset, suggesting cumulative trauma exposure has measurable physiological effects on reproductive aging. • The ovary inflammation finding is early-stage research; it hasn't yet established a direct causal chain from cellular identity shift to specific symptoms, which means it warrants attention but not alarm. • The violence-menopause link adds to a growing body of evidence that chronic stress and trauma accelerate biological aging in women — a factor rarely addressed in standard menopause care. Sources & References: • Ovary identity shift after menopause may contribute to inflammation (https://news.google.com/rss/articles/CBMiswFBVV95cUxQMzlwNUd0bWg0Wm5QeGpoNWpYUDhocDJYb056Y3VfU3lxSF9xUEsyZnM1bGlWUDBCLWNDMFNEazFXR0lOQzZhaV9rOGJ3ckhFSmFUYVBHbVgxQlFDQXc0ZkFwd2ZwR1BZZzlxdC1sTmpjS040d3NMLVlkUkQzbDVJUGxwMDZfWUV0WTdXOGw4MkJhcmJOZDJQMnBYUkIwcXk5WHZxYURuQmhONWUySTJFQlkwQQ) - New Scientist • Women are "petrified" after Penélope Cruz and Olivia Wilde discussed a perimenopause symptom they had no idea existed (https://news.google.com/rss/articles/CBMingFBVV95cUxPa3lQNXozdklhaU1RYU1Ub1lmOHdTTWd5dWhLdHg5N1RZZEFsTTdnRzhCcXh2b3k0QmdhR3FFUFMxanFReW04cGc0WmN0TXh0bTJzU3A4SkFkd2ZEanl0UGhnZmNobGtVaVBjdl9TRndybE95NjQyWGZHSHZBeDIweGxrSk5CTmVCVVBjZUc0UW1HSFlTdXFCVFRwWHp1Zw) - BuzzFeed • Lifelong violence against women linked to significantly earlier menopause onset (https://news.google.com/rss/articles/CBMivgFBVV95cUxNRnRLVHh1cTJRZkVkQUY4Rkxad0RYUl9udG1sVFB1Q0luLXdFb3N1NFRPN1laYmFkU0JQWmU2b2hOOGdmZFMtb2sxRWVpNnRRQ2FCMVdwdlJPQzNfOEVNVmw3bE9xUlFOLWxoZzg3RDFzak5mVHpkUmRXekp5emtfUHdVal84QmNGaEJOYXNXbEY3NFVDc2pvODhnRThNejJHbEs5ODZXUVhlQ1lRalpudHc5VjhZcUszclRNRzFR) - News-Medical Listen with full show notes: https://hotflasher.com/episodes/2026-07-07-symptom-spotlight Have a menopause story to share? We'd love to hear it: https://hotflasher.com/share --- Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.

See All (81)

Ratings & Reviews

5
out of 5
2 Ratings

About

Hot Flasher. Daily menopause podcast. Because we all had the same question and nobody had a good answer.

Information

  • Creator
    Hot Flasher
  • Years Active
    2026
  • Episodes
    81
  • Rating
    Clean
  • Show Website
    Hot Flasher